期刊
NEUROLOGICAL SCIENCES
卷 41, 期 7, 页码 1647-1650出版社
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s10072-020-04519-x
关键词
Multiple Sclerosis; Remote monitoring technologies; COVID-19
资金
- EU/EFPIA IMI Joint Undertaking 2 (RADAR-CNS) [115902]
- MRC [MC_PC_17214] Funding Source: UKRI
We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据